¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) Á¦35Â÷ ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ : 2020-08-01

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) Á¦35Â÷ ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ : 2020-08-01
±³À°ÀÏÀÚ : 2020-08-01
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À° (½Ç½Ã°£ È­»ó°­ÀÇ/¿Ü±¹ÀÎ ¿¬ÀÚ ³ìÈ­°­¿¬ ¿µ»ó ¼ÛÃâ)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦35Â÷ ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
´ã´çÀÚ : ÇѼ¼¹Ì
¿¬¶ôó : 02-512-0040  
À̸ÞÀÏ : gyncancer@gyncancer.or.kr      
±³À°Á¾·ù : »êºÎÀΰú      
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 10 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í Àü¹®ÀÇ: 60,000 / Àü°øÀÇ: 45,000 / ¿¬±¸¿ø,°£È£»ç: 30,000 / ÁÂÀå,¿¬ÀÚ, ¸¸65¼¼ÀÌ»ó: ¹«·á      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 08¿ù 01ÀÏ E-Conference 09:00~09:10 Opening Remarks  ±è½Âö(´ëÇѺÎÀÎÁ¾¾çÇÐȸ ȸÀå) 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 09:10~09:25 COVID-19 & gyn cancer: management and research status  ½Å¼ÒÁø(°è¸íÀÇ´ë) 
Åä·Ð 08¿ù 01ÀÏ E-Conference 09:25~09:30 Discussion  () 
Åä·Ð 08¿ù 01ÀÏ E-Conference 09:30~10:30 [6 topics] - 10min / 1topic (each: 8min presentation / 2min discussion)  () 
È޽Ġ08¿ù 01ÀÏ E-Conference 10:30~10:50 Coffee Break  () 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 10:50~11:10 Controversial issues in gynaecological oncology  Neville Hacker(Univ. of NSW Australia) 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 11:10~11:30 Molecular and endocrine-targeted therapeutic options for endometrial cancer  Hidetaka Katabuchi(Kumamoto Univ. Japan) 
Åä·Ð 08¿ù 01ÀÏ E-Conference 11:30~11:40 Discussion  () 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 11:40~12:00 Are we about to cure ovarian cancer  Mansoor Raza Mirza(Copenhagen Univ. Denmark) 
½Ä»ç 08¿ù 01ÀÏ E-Conference 12:00~13:30 Lunch  () 
Åä·Ð 08¿ù 01ÀÏ E-Conference 13:30~15:00 (9 topics) - 10min/1topic (each: 8min presentation / 2min discussion)  () 
È޽Ġ08¿ù 01ÀÏ E-Conference 15:00~15:20 Coffee Break  () 
Åä·Ð 08¿ù 01ÀÏ E-Conference 15:20~16:30 (7 topics) - 10min/1topic (each: 8min presentation / 2min discussion)  () 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 16:30~16:45 Cervical cancer  À̱ÙÈ£(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 16:45~17:00 Endometrial cancer  ±è´ë¿¬(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 17:00~17:15 Ovarian cancer  Àå¼®ÁØ(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 17:15~17:30 Cervical cancer screening  ÀÌÅûó(¼­¿ïÀÇ´ë) 
Åä·Ð 08¿ù 01ÀÏ E-Conference 17:30~17:45 Discussion  () 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 11:40~12:00 Prevention of chemotherapy-induced nausea and vomiting (CINV), NOT treatment  ÃÖ¹Îö(Â÷ÀÇ´ë) 
½Ä»ç 08¿ù 01ÀÏ E-Conference 12:00~13:30 Lunch  () 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 13:30~13:50 Surgical principles and tips to avoid complications  ±èÀ±È¯(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 13:50~14:10 Bowel complications  ÇãÇõ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 14:10~14:30 Urologic complications  ±è¼±ÀÏ(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 14:30~14:50 Vascular complications  È«ÁØÈ­(Áß¾ÓÀÇ´ë) 
Åä·Ð 08¿ù 01ÀÏ E-Conference 14:50~15:00 Discussion  () 
È޽Ġ08¿ù 01ÀÏ E-Conference 15:00~15:20 Coffee Break  () 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 15:20~15:35 Predictive model for lymph node metastasis using PET/CT and sentinel node mapping in endometrial cancer  ÀÓö±Ç(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 15:35~15:50 Comparison of tumor-infiltrating lymphocytes according to BRCA1/2 status in patients with serous ovarian cancer  ¹ÚÁؽÄ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 15:50~16:05 Validation of potential protein markers predicting chemoradioresistance in early cervical cancer by immunohistochemical staining  Á¤¼ö¿µ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 16:05~16:20 Peripheral blood BRCA1 methylation profiling to predict family ovarian cancer  Á¤À¯¿¬(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 16:20~17:00 Meta-analysis ³í¹®¾²±â I: ³í¹®°Ë»öºÎÅÍ Åë°è ºÐ¼® ¿ø¸®±îÁö  À̹æÇö(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 17:00~17:40 Meta-analysis ³í¹®¾²±â II: Åë°èºÐ¼® ½ÇÁ¦¿Í ÃâÆÇ³í¹® ¿¹½Ã  ±èÈñ½Â(¼­¿ïÀÇ´ë) 
Åä·Ð 08¿ù 01ÀÏ E-Conference 17:40~17:45 Discussion  () 
±âŸ 08¿ù 01ÀÏ E-Conference 17:45~18:00 ½Ådzȣ¿ùÇмú»ó ½Ã»ó  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) Á¦35Â÷ ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ : 2020-08-01""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦38Â÷ ¿Â¶óÀÎ Ãá°èÇмú´ëȸ_2nd Day : 2020-08-01
´ÙÀ½±Û (¿Â¶óÀÎ)Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¤½ÅÄ¡·á Áõ·Ê¹ßÇ¥ : 2020-08-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 37 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 35 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 31 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 27 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 31 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 47 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 25 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 24 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 24 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 22 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 20 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 23 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 28 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 28 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷